Albert David Limited Share Price NSE India S.E.

ALBERTDAVD

INE155C01010

Pharmaceuticals

Market Closed - NSE India S.E. 12:05:07 15/09/2026 BST			5-day change	1st Jan Change
851.90 ^INR	+0.89%		+0.93%	+15.65%

08-06	Albert David Limited Reports Earnings Results for the First Quarter Ended June 30, 2026	CI
08-06	Albert David Limited Approves Appointment of Mr. Amit Mahla as Whole-Time Director, effective 19 June, 2026	CI

Valuation: Albert David Limited

Market Cap	4.84B 50.53M 43.79M 41.32M 37.49M 70.32M 70.83M 494M 190M 2.46B 190M 186M 7.81B	P/E 2025	26.9x	P/E 2026	-224x
Enterprise Value	2.56B 26.74M 23.17M 21.87M 19.84M 37.22M 37.49M 261M 101M 1.3B 100M 98.24M 4.13B	EV / Sales 2025	0.67x	EV / Sales 2026	0.32x
Free-Float	35.96%	Yield 2025	0.62%	Yield 2026	0.85%

* Estimated data More valuation ratios

Latest news: Albert David Limited

08-06	Albert David Limited Reports Earnings Results for the First Quarter Ended June 30, 2026	CI
08-06	Albert David Limited Approves Appointment of Mr. Amit Mahla as Whole-Time Director, effective 19 June, 2026	CI
08-06	Albert David Limited Announces Resignation of Kuntal Ganguly from Head- R&D, Effective August 5, 2026	CI
05-30	Albert David Limited Announces Resignation of Chandra Bhushan Thakur from Head-Operations, Effective May 29, 2026	CI
05-12	Albert David appoints Amit Mahla as CEO effective May 12	RE
05-12	Albert David Limited Announces Appointment of Amit Mahla as the Chief Executive Officer with Effect from May 12, 2026	CI
05-12	Albert David Limited Announces Appointment of Amit Mahla as the Key Managerial Personnel with Effect from May 12, 2026	CI
05-12	Albert David Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026	CI
05-11	Albert David Limited announces Annual dividend, payable on September 05, 2026	CI
02-11	Albert David Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025	CI
12-19	Albert David says Umesh Manohar Kunte resigns as MD, CEO	RE
12-18	Albert David says Umesh Manohar Kunte resigns as managing director and CEO	RE
12-18	Albert David Limited Announces Resignation of CEO Umesh Manohar Kunte, Effective December 18, 2025	CI

More news

Managers and Directors: Albert David Limited

Manager	Title	Age	Since
Amit Mahla CEO	Chief Executive Officer	52	11/05/2026
Ranadeep Bhattacharya DFI	Director of Finance/CFO	-	30/11/2020
Lalit Lohia CMP	Compliance Officer	-	-

Director	Title	Age	Since
Arun Kumar Kothari CHM	Chairman	73	29/12/2009
Prabhawati Devi Kothari BRD	Director/Board Member	69	30/03/2014
Monjori Mitra BRD	Director/Board Member	64	23/08/2020

More insiders

Albert David Limited is an India-based pharmaceutical company. The Company's principal business is manufacturing and trading of pharmaceutical formulations, infusion solutions, herbal dosage forms and bulk drugs by way of domestic sale or export. Its product categories include formulations and bulk drugs. Its product range includes Placentrex range, Anaflam range and BREAZE range. Its formulations include parenteral, oral/enteral, topical agents and vision care. Its parenteral categories include amino acids infusion, anti-microbial, anti-leishmaniasis (kalazar), haemostat (inj), lvp, neurotropic vitamin and placenta extract. The Company's oral/enteral categories include amino acids oral, anthelmintic, anti-microbial, anti-ulcer ants, anti-vertigo, appetite stimulants, anti-tubercular, expectorant / cough syrup, hematinic, haemostat, hepato protective (ayurveda) and hepato protective (others). Its vision care categories include anti glaucoma, anti-infective and NSAID.

Employees

1,476

Sector

Pharmaceuticals

More about the company

Quotes

Date	Price	Change	Volume
15/09/26	₹851.90	+0.89%	5,779
11/09/26	₹844.35	-0.66%	2,805
10/09/26	₹850.00	-0.06%	1,634
09/09/26	₹850.55	+0.77%	3,812
08/09/26	₹844.05	-2.20%	6,478

Delayed Quote NSE India S.E.

More quotes

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!

SEIZE THE OFFER!

1 day	+0.89%
1 week	+0.93%
Current month	-5.12%
1 month	+5.68%
3 months	+18.10%
6 months	+26.38%
Current year	+15.65%

1 week	832	862.85
1 month	791.2	931.85
Current year	579.9	931.85
1 year	579.9	931.85
3 years	579.9	1,753.95
5 years	486.85	1,753.95
10 years	263	1,753.95

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ALBERT DAVID LIMITED	+0.89%	+0.93%	-	-	50.38M
SUN PHARMACEUTICAL INDUSTRIES LTD.	-0.27%	-2.70%	+14.54%	+59.59%	46.06B
OTSUKA HOLDINGS CO., LTD.	+1.42%	-3.18%	+34.81%	+106.00%	38.29B
ZYDUS LIFESCIENCES LIMITED	-1.80%	-4.06%	+5.99%	+70.30%	11.65B
CIPLA LIMITED	-1.10%	-2.38%	-12.74%	+9.35%	11.51B
KRKA, D. D.	+0.96%	+0.19%	+19.32%	+148.82%	9.17B
GEDEON RICHTER	-0.04%	-0.08%	+23.96%	+36.63%	7.22B
GLENMARK PHARMACEUTICALS LIMITED	-1.96%	-4.15%	+12.96%	+176.91%	7.12B
ONO PHARMACEUTICAL CO., LTD.	+0.68%	-2.93%	+35.03%	-19.88%	7.11B
SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD.	+0.60%	-3.42%	-44.55%	+12.16%	4.99B
Average	-0.06%	-1.72%	+9.93%	+66.65%	15.9B
Weighted average by Cap.	+0.07%	-2.47%	+16.73%	+73.63%

	2025	2026
Net sales	3.46B 36.08M 31.26M 29.5M 26.76M 50.2M 50.57M 352M 136M 1.75B 135M 133M 5.58B	3.34B 34.81M 30.16M 28.46M 25.82M 48.44M 48.79M 340M 131M 1.69B 131M 128M 5.38B
Net income	172M 1.79M 1.56M 1.47M 1.33M 2.5M 2.52M 17.53M 6.75M 87.26M 6.74M 6.59M 277M	-14.95M -156K -135K -128K -116K -217K -219K -1.52M -587K -7.58M -586K -573K -24.11M
Net Debt	-2.31B -24.14M -20.91M -19.74M -17.91M -33.59M -33.83M -236M -90.83M -1.17B -90.65M -88.66M -3.73B	-2.28B -23.79M -20.61M -19.45M -17.65M -33.1M -33.34M -232M -89.52M -1.16B -89.35M -87.38M -3.68B

Albert David Limited Share Price NSE India S.E.

Stocks

ALBERTDAVD

INE155C01010

Pharmaceuticals

Valuation: Albert David Limited

Chart: Albert David Limited

Latest news: Albert David Limited

Quotes and Performance

Price Extremes

Managers and Directors: Albert David Limited

Generic Pharmaceuticals

Financials

Company Profile

Quotes